首页> 外文学位 >An analysis of third-party regulatory audit systems for medical device safety.
【24h】

An analysis of third-party regulatory audit systems for medical device safety.

机译:对医疗器械安全性第三方监管审核系统的分析。

获取原文
获取原文并翻译 | 示例

摘要

Auditing the quality process used to manufacture medical products provides benefits for multiple stakeholders. Assurance that the manufacturing process follows acceptable standards of quality provides stakeholders with confidence that manufacturing-related risks and adverse events are minimized. When government provides this protection, the resources required to audit and assure regulatory compliance proves to be costly. Foreign governments have adopted private auditing systems in response to reduced government budgets and global markets' demands for uniform auditing systems.;The purpose of this exploratory, descriptive research study was to help government officials, public administrators and stakeholders become more effective decision makers, managers and participants by enhancing their knowledge of the implications of cost and accountability when privatizing regulatory audits for quality manufacturing of medical devices. The objectives of the study were: (1) to examine the costs and benefits of privatization with respect to efficiency and accountability, (2) to evaluate privatized models in use by other governments, and (3) to evaluate the use of third parties in conducting Food and Drug Administration (FDA) medical device inspections.;This study utilized a combination of qualitative and quantitative research methodologies and secondary data analysis. The information and data were collected from a critical review of the literature involving privatization of audits, in-depth interviews and discussions with representatives from the FDA and international governing bodies that audit medical device manufacturing quality, and various government documents.;This study concluded that with training and experience, third parties can conduct inspections comparable to the FDA with respect to detecting manufacturing deficiencies in an equivalent inspection time period. Findings also suggest that while production costs may not be significantly different, transaction costs associated with the need for continuous communication, training and monitoring may cancel savings realized or increase the cost of having third parties conduct inspections. The study also indicated that concerns about accountability when cost savings are the driving force for privatization could be reduced if government balances their control and production in the audit process.
机译:审核用于生产医疗产品的质量流程可为多个利益相关者带来好处。确保制造过程遵循可接受的质量标准,使利益相关者有信心将与制造相关的风险和不良事件降到最低。当政府提供这种保护时,审核和确保合规性所需的资源被证明是昂贵的。为了减少政府预算和全球市场对统一审计系统的需求,外国政府采用了私人审计系统。这项探索性,描述性研究的目的是帮助政府官员,公共管理人员和利益相关者成为更有效的决策者,管理者。和参与者,通过在对医疗器械的高质量制造进行监管审核私有化时增强对成本和问责制含义的了解。该研究的目标是:(1)考察私有化在效率和责任制方面的成本和收益;(2)评估其他政府使用的私有化模型;(3)评估第三方在以下方面的使用:进行食品和药物管理局(FDA)医疗器械检查。;本研究结合了定性和定量研究方法以及辅助数据分析。信息和数据来自对包括审计私有化的文献的严格审查,与FDA和审核医疗器械制造质量的国际理事机构代表的深入访谈和讨论以及各种政府文件的收集。借助培训和经验,第三方可以在等效的检查时间内进行与FDA相当的检查,以检测制造缺陷。研究结果还表明,尽管生产成本可能没有显着差异,但是与持续沟通,培训和监控的需求相关的交易成本可能会取消已实现的节省或增加让第三方进行检查的成本。该研究还表明,如果政府在审计过程中平衡控制和生产,则可以减少对成本节约是私有化驱动力时的问责制的担忧。

著录项

  • 作者

    Gill, Lillian J.;

  • 作者单位

    University of Southern California.;

  • 授予单位 University of Southern California.;
  • 学科 Health Sciences Public Health.;Political Science Public Administration.
  • 学位 D.P.A.
  • 年度 2004
  • 页码 147 p.
  • 总页数 147
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号